enVVeno Medical (NVNO) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | EnVVeno Medical To Present Data From VenoValve Trial At 51st Annual VEITH Symposium; Data Includes Showing 85% Clinical Meaningful Benefit Responder Rate, 87% Median Ulcer Area Reduction
BenzingaNov 20 08:33 ET
EnVVeno Medical to Present Definitive One Year Data From the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
AccesswireNov 20 08:30 ET
EnVVeno Medical Submits PMA Application To FDA To Sell And Market VenoValve In The US
BenzingaNov 19 08:17 ET
EnVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
AccesswireNov 19 08:15 ET
10-Q: Q3 2024 Earnings Report
SECOct 31 12:59 ET · Announcements
EnVVeno Medical Q3 EPS $(0.35) Misses $(0.33) Estimate
BenzingaOct 31 09:03 ET

Comments

Trytosaveabit

Nov 19 07:19

News

$enVVeno Medical (NVNO.US)$ enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
3 MINUTES AGO, 8:15 AM EST
VIA ACCESSWIRE
Definitive One Year Data from PMA Application to be Presented Wednesday at 51st Annual VEITH Symposium
Company to Host a Conference Call with the PIs Presenting the Pivotal Trial Data on Wednesday, November 20th at 2:00 PM Eastern Time

1

Jaguar8

Nov 19 07:16

NEWS

$enVVeno Medical (NVNO.US)$
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
enVVeno Medical has submitted its PMA application to the FDA for the VenoValve, seeking marketing and sales approval in the United States. Four out of five modules have been approved, with the final module containing clinical data from the SAVVE pivotal trial and proposed labeling.
The FDA-designated breakthrough device aims to treat severe deep venous Chronic Venous Insufficiency (CVI), ta...

1

Trytosaveabit

Oct 28 07:38

Update

$enVVeno Medical (NVNO.US)$ enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
7 MINUTES AGO, 8:30 AM EDT
VIA ACCESSWIRE
First wave of implants successfully completed with updated delivery system performing very well
Company on schedule to be in position to apply for approval for enVVe pivotal trial mid-2025

Trytosaveabit

Sep 29 14:24

May be time to start a swing! NFA

$enVVeno Medical (NVNO.US)$ Saying this for a few reasons! But the big drop from the offering makes a nice bottom! And Y’all knows i likes me some bottoms! Hehehe. Crash from offering gave a 52wk low! But they also only had 1 last module to complete before submitting to FDA for PMA! That was / is to be complete Q4! So that brings me to my speculative part of my interest! Hehehe. Is it very possible that they did the offering now so they have the money going forwar...

5

4

Jaguar8

Sep 26 21:27

NEWS

$enVVeno Medical (NVNO.US)$
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public OfferingenVVeno Medical (NASDAQ:NVNO) has announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock (or pre-funded warrants) at $3.50 per share. The company expects to receive gross proceeds of approximately $15.0 millionfrom the offering, excluding underwriting discounts and other expenses. The offering is expected to close around September 30, 2024.
The co...

4

NVNO enVVeno Medical

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target